Indivior Pharmaceuticals Statistics
Total Valuation
SPUN has a market cap or net worth of $4.28 billion. The enterprise value is $4.48 billion.
| Market Cap | 4.28B |
| Enterprise Value | 4.48B |
Important Dates
The next estimated earnings date is Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SPUN has 118.04 million shares outstanding. The number of shares has decreased by -0.98% in one year.
| Current Share Class | 118.04M |
| Shares Outstanding | 118.04M |
| Shares Change (YoY) | -0.98% |
| Shares Change (QoQ) | -1.61% |
| Owned by Insiders (%) | 1.84% |
| Owned by Institutions (%) | 98.56% |
| Float | 109.48M |
Valuation Ratios
The trailing PE ratio is 10.21 and the forward PE ratio is 8.25.
| PE Ratio | 10.21 |
| Forward PE | 8.25 |
| PS Ratio | 3.12 |
| Forward PS | 3.11 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 138.14 |
| P/OCF Ratio | 44.61 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.87, with an EV/FCF ratio of 144.46.
| EV / Earnings | 9.95 |
| EV / Sales | 3.26 |
| EV / EBITDA | 6.87 |
| EV / EBIT | 6.94 |
| EV / FCF | 144.46 |
Financial Position
The company has a current ratio of 0.61
| Current Ratio | 0.61 |
| Quick Ratio | 0.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | 0.75 |
| Debt / FCF | 16.16 |
| Interest Coverage | 40.31 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 29.34% |
| Return on Invested Capital (ROIC) | 272.47% |
| Return on Capital Employed (ROCE) | 2,080.65% |
| Weighted Average Cost of Capital (WACC) | 9.66% |
| Revenue Per Employee | $1.64M |
| Profits Per Employee | $536,993 |
| Employee Count | 838 |
| Asset Turnover | 1.00 |
| Inventory Turnover | 1.29 |
Taxes
In the past 12 months, SPUN has paid $88.00 million in taxes.
| Income Tax | 88.00M |
| Effective Tax Rate | 16.36% |
Stock Price Statistics
The stock price has increased by +23.53% in the last 52 weeks. The beta is 1.13, so SPUN's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | +23.53% |
| 50-Day Moving Average | 35.18 |
| 200-Day Moving Average | 35.68 |
| Relative Strength Index (RSI) | 58.42 |
| Average Volume (20 Days) | 2,933,603 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SPUN had revenue of $1.37 billion and earned $450.00 million in profits. Earnings per share was $3.55.
| Revenue | 1.37B |
| Gross Profit | 1.18B |
| Operating Income | 645.00M |
| Pretax Income | 538.00M |
| Net Income | 450.00M |
| EBITDA | 652.00M |
| EBIT | 645.00M |
| Earnings Per Share (EPS) | $3.55 |
Balance Sheet
The company has $305.00 million in cash and $501.00 million in debt, with a net cash position of -$196.00 million or -$1.66 per share.
| Cash & Cash Equivalents | 305.00M |
| Total Debt | 501.00M |
| Net Cash | -196.00M |
| Net Cash Per Share | -$1.66 |
| Equity (Book Value) | -60.00M |
| Book Value Per Share | -0.51 |
| Working Capital | -501.00M |
Cash Flow
In the last 12 months, operating cash flow was $96.00 million and capital expenditures -$65.00 million, giving a free cash flow of $31.00 million.
| Operating Cash Flow | 96.00M |
| Capital Expenditures | -65.00M |
| Depreciation & Amortization | 7.00M |
| Net Borrowing | 151.00M |
| Free Cash Flow | 31.00M |
| FCF Per Share | $0.26 |
Margins
Gross margin is 85.74%, with operating and profit margins of 46.94% and 32.75%.
| Gross Margin | 85.74% |
| Operating Margin | 46.94% |
| Pretax Margin | 39.16% |
| Profit Margin | 32.75% |
| EBITDA Margin | 47.45% |
| EBIT Margin | 46.94% |
| FCF Margin | 2.26% |
Dividends & Yields
SPUN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.98% |
| Shareholder Yield | 0.98% |
| Earnings Yield | 9.79% |
| FCF Yield | 0.72% |
Analyst Forecast
The average price target for SPUN is $49.50, which is 36.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $49.50 |
| Price Target Difference | 36.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.32% |
| EPS Growth Forecast (3Y) | 28.18% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 10, 2022. It was a reverse split with a ratio of 1:5.
| Last Split Date | Oct 10, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
SPUN has an Altman Z-Score of 3.79 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.79 |
| Piotroski F-Score | 5 |